Company intelligence / Profile preview

KLIFO

Ownership: Private
Employees: ~160
Development stage: Other

Overview

As a leading North European drug development consultancy/CRO with over 30 years of experience and more than 160 staff in four countries, KLIFO provides end-to-end solutions for pharmaceutical and biotech companies across the full spectrum of drug development. It offers strategic advice and operational support in project management, regulatory affairs, clinical operations/trials (early to late phase), CMC development, QA/GMP compliance, pharmacovigilance and clinical trial supply. The company has been acquired by Gilde Healthcare to support international growth ambitions.

Therapeutic areas: OncologyGastroenterologyNeurologyOther
Modalities: small moleculesbiologicsmAbs
Industry: Consulting

Beyond the preview

Go deeper on KLIFO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLIFO.

Explore the full profile